MorphoSys AG

MorphoSys AGverified

MPSYF

Price:

$73.27

Market Cap:

$2.45B

MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule that is in Phase II clinical trial to treat myelofibrosis; Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease; and CPI-0209, a ...[Read more]

Industry

Biotechnology

IPO Date

2010-04-28

Stock Exchange

OTC

Ticker

MPSYF

The Enterprise Value as of November 2025 (TTM) for MorphoSys AG (MPSYF) is 2.93B

According to MorphoSys AG’s latest financial reports and current stock price. The company's current Enterprise Value is 2.93B. This represents a change of 78.67% compared to the average of 1.64B of the last 4 quarters.

MorphoSys AG (MPSYF) Historical Enterprise Value (quarterly & annually)

How has MPSYF Enterprise Value performed in the past?

The mean historical Enterprise Value of MorphoSys AG over the last ten years is 2.30B. The current 2.93B Enterprise Value has changed 12.62% with respect to the historical average. Over the past ten years (40 quarters), MPSYF's Enterprise Value was at its highest in in the December 2019 quarter at 4.03B. The Enterprise Value was at its lowest in in the December 2022 quarter at 394.03M.

Quarterly (TTM)
Annual

Average

2.30B

Median

2.45B

Minimum

393.89M

Maximum

4.02B

MorphoSys AG (MPSYF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MorphoSys AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 333.27%

Maximum Annual Enterprise Value = 4.02B

Minimum Annual Increase = -69.92%

Minimum Annual Enterprise Value = 393.89M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.71B333.27%
2022393.89M-69.92%
20211.31B-59.89%
20203.26B-18.77%
20194.02B47.73%
20182.72B10.57%
20172.46B-4.19%
20162.57B5.15%
20152.44B13.55%
20142.15B19.00%

MorphoSys AG (MPSYF) Average Enterprise Value

How has MPSYF Enterprise Value performed in the past?

The current Enterprise Value of MorphoSys AG (MPSYF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.14B

5-year avg

2.14B

10-year avg

2.30B

MorphoSys AG (MPSYF) Enterprise Value vs. Peers

How is MPSYF’s Enterprise Value compared to its peers?

MorphoSys AG’s Enterprise Value is less than Takara Bio Inc. (82.75B), less than Ascentage Pharma Group International (21.50B), less than Indivior PLC (3.93B), less than Sugi Holdings Co.,Ltd. (606.93B), less than Indivior PLC (3.93B), less than Nihon Kohden Corporation (250.32B), greater than Biotest AG (2.02B), less than Alfresa Holdings Corporation (271.58B), greater than Mithra Pharmaceuticals S.A. (211.34M), greater than Pascal Biosciences Inc. (6.12M),

Build a custom stock screener for MorphoSys AG (MPSYF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MorphoSys AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MorphoSys AG (MPSYF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MorphoSys AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is MorphoSys AG's Enterprise Value?

What is the highest Enterprise Value for MorphoSys AG (MPSYF)?

What is the 3-year average Enterprise Value for MorphoSys AG (MPSYF)?

What is the 5-year average Enterprise Value for MorphoSys AG (MPSYF)?

How does the current Enterprise Value for MorphoSys AG (MPSYF) compare to its historical average?